搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
3 小时
Stocks To Watch: Tata Motors, Cipla, Religare, ONGC, Cochin Shipyard, And Others
Shares of firms like Tata Motors, Cipla, Religare, ONGC, Cochin Shipyard, and others will be in focus on Monday's trade ...
emjreviews.com
4 小时
Women with PsA Experience Longer Time to Diagnosis than Men
Women with psoriatic arthritis endure longer diagnostic delays and report higher pain levels than men. Learn about sex-based ...
News Medical
5 小时
Ultra-processed foods increase active psoriasis risk, study shows
This study highlights a significant link between high ultra-processed food (UPF) consumption and active psoriasis, ...
Onlymyhealth
10 小时
Nourish, Protect, and Heal: Here's How Black Cumin Seed Oil Can Transform Your Skin
Adding black cumin seed oil to your skincare routine offers benefits like hydration anti-ageing acne control and protection ...
India Infoline
11 小时
Biocon Secures FDA Approval for Innovative Autoimmune Drug YESINTEK
Collaboration with Janssen aims to fast-track the launch and enhance accessibility to YESINTEK for patients in need.
healthshots
12 小时
How does sugar affect your skin? 5 side effects of it
Other side effect of the link between sugar and skin health is psoriasis. It is an autoimmune condition that causes red, ...
Medindia
12 小时
Ultra-Processed Foods Linked to Psoriasis Flare-Ups
Could ultra-processed foods be fueling your psoriasis? A new study suggests a link between high consumption of these foods ...
13 小时
USFDA approves Biocon Biologics' biosimilar for Crohn's disease, psoriasis
YESINTEK, a monoclonal antibody, is approved for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
14 小时
Biocon Biologics gets US nod to launch Stelara biosimilar
Biocon Biologics has secured USFDA approval to launch the biosimilar of Janssen's Stelara by February 2025, targeting ...
The Financial Express
15 小时
USFDA gives nod to Biocon Biologics’ biosimilar to treat Crohn’s disease
The biosimilar is approved for the treatment of Crohn’s disease, Ulcerative Colitis, Plaque Psoriasis and Psoriatic Arthritis ...
ndtvprofit
16 小时
Biocon Biologics Receives US FDA Nod For Yesintek, A Biosimilar to J&J's Stelara
Biocon Biologics Ltd (BBL) has received US Food and Drug Administration (FDA) approval for Yesintek, a biosimilar for Johnson ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈